AR043949A1 - Preparacion de clorhidrato de quinapril - Google Patents
Preparacion de clorhidrato de quinaprilInfo
- Publication number
- AR043949A1 AR043949A1 ARP040101036A ARP040101036A AR043949A1 AR 043949 A1 AR043949 A1 AR 043949A1 AR P040101036 A ARP040101036 A AR P040101036A AR P040101036 A ARP040101036 A AR P040101036A AR 043949 A1 AR043949 A1 AR 043949A1
- Authority
- AR
- Argentina
- Prior art keywords
- quinapril
- acid
- chlorhydrate
- preparation
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describen procedimientos y materiales para preparar quinapril, sus sales farmacéuticamente aceptables, incluyendo clorhidrato de quinapril. El procedimiento incluye hacer reaccionar el éster etílico del ácido (2S,4S)-2-(4-metil-2,5-dioxo-oxazolidin-3-il)-4-fenilbutírico con el éster terc-butílico del ácido (3S)-1,2,3,4-tetrahidro-isoquinolin-3-carboxílico para dar el éster terc-butílico de quinapril, el cual se hace reaccionar posteriormente con un ácido para dar quinapril o una sal de adición de ácido de quinapril.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45901603P | 2003-03-31 | 2003-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR043949A1 true AR043949A1 (es) | 2005-08-17 |
Family
ID=33131855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040101036A AR043949A1 (es) | 2003-03-31 | 2004-03-29 | Preparacion de clorhidrato de quinapril |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6858735B2 (es) |
| EP (1) | EP1611106B1 (es) |
| JP (1) | JP2006522092A (es) |
| KR (1) | KR20050115323A (es) |
| CN (1) | CN1747935A (es) |
| AR (1) | AR043949A1 (es) |
| AT (1) | ATE340161T1 (es) |
| AU (1) | AU2004226154B2 (es) |
| BR (1) | BRPI0408924A (es) |
| CA (1) | CA2517451C (es) |
| CL (1) | CL2004000541A1 (es) |
| DE (1) | DE602004002473T2 (es) |
| DK (1) | DK1611106T3 (es) |
| ES (1) | ES2271868T3 (es) |
| MX (1) | MXPA05010498A (es) |
| PL (1) | PL1611106T3 (es) |
| PT (1) | PT1611106E (es) |
| RS (1) | RS20050597A (es) |
| RU (1) | RU2298004C2 (es) |
| TW (1) | TWI284637B (es) |
| WO (1) | WO2004087671A1 (es) |
| ZA (1) | ZA200505214B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009053994A1 (en) * | 2007-10-26 | 2009-04-30 | Matrix Laboratories Limited | Process for preparing pure amorphous quinapril hydrochloride |
| US10278742B2 (en) | 2012-11-12 | 2019-05-07 | DePuy Synthes Products, Inc. | Interbody interference implant and instrumentation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4344949A (en) * | 1980-10-03 | 1982-08-17 | Warner-Lambert Company | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
| US4686295A (en) * | 1982-03-10 | 1987-08-11 | Usv Pharmaceutical Corporation | N-carboxy anhydride intermediates |
| US4761479A (en) * | 1987-03-30 | 1988-08-02 | Warner-Lambert Company | Crystalline quinapril and a process for producing the same |
| WO2002018321A2 (en) * | 2000-08-29 | 2002-03-07 | Abbott Laboratories | Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| US6541635B1 (en) * | 2002-03-29 | 2003-04-01 | Everlight Usa, Inc. | Method for producing angiotensin converting enzyme inhibitor |
| US7482361B2 (en) * | 2002-12-16 | 2009-01-27 | Lupin Limited | Crystalline form for quinapril hydrochloride and process for preparing the same |
-
2004
- 2004-03-16 CL CL200400541A patent/CL2004000541A1/es unknown
- 2004-03-19 CA CA002517451A patent/CA2517451C/en not_active Expired - Fee Related
- 2004-03-19 PT PT04721968T patent/PT1611106E/pt unknown
- 2004-03-19 AT AT04721968T patent/ATE340161T1/de not_active IP Right Cessation
- 2004-03-19 DK DK04721968T patent/DK1611106T3/da active
- 2004-03-19 JP JP2006506407A patent/JP2006522092A/ja not_active Withdrawn
- 2004-03-19 CN CNA2004800040018A patent/CN1747935A/zh active Pending
- 2004-03-19 DE DE602004002473T patent/DE602004002473T2/de not_active Expired - Fee Related
- 2004-03-19 ES ES04721968T patent/ES2271868T3/es not_active Expired - Lifetime
- 2004-03-19 RU RU2005130402/04A patent/RU2298004C2/ru not_active IP Right Cessation
- 2004-03-19 EP EP04721968A patent/EP1611106B1/en not_active Expired - Lifetime
- 2004-03-19 MX MXPA05010498A patent/MXPA05010498A/es not_active Application Discontinuation
- 2004-03-19 AU AU2004226154A patent/AU2004226154B2/en not_active Ceased
- 2004-03-19 WO PCT/IB2004/000942 patent/WO2004087671A1/en active IP Right Grant
- 2004-03-19 KR KR1020057018421A patent/KR20050115323A/ko not_active Application Discontinuation
- 2004-03-19 RS YUP-2005/0597A patent/RS20050597A/sr unknown
- 2004-03-19 BR BRPI0408924-3A patent/BRPI0408924A/pt not_active IP Right Cessation
- 2004-03-19 PL PL04721968T patent/PL1611106T3/pl unknown
- 2004-03-23 US US10/806,707 patent/US6858735B2/en not_active Expired - Fee Related
- 2004-03-29 AR ARP040101036A patent/AR043949A1/es not_active Application Discontinuation
- 2004-03-30 TW TW093108753A patent/TWI284637B/zh not_active IP Right Cessation
-
2005
- 2005-06-28 ZA ZA200505214A patent/ZA200505214B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040192613A1 (en) | 2004-09-30 |
| BRPI0408924A (pt) | 2006-04-04 |
| PT1611106E (pt) | 2006-11-30 |
| RU2005130402A (ru) | 2006-02-10 |
| CL2004000541A1 (es) | 2005-02-04 |
| ZA200505214B (en) | 2008-08-27 |
| RS20050597A (en) | 2007-09-21 |
| TW200424177A (en) | 2004-11-16 |
| DE602004002473D1 (de) | 2006-11-02 |
| ES2271868T3 (es) | 2007-04-16 |
| US6858735B2 (en) | 2005-02-22 |
| JP2006522092A (ja) | 2006-09-28 |
| CN1747935A (zh) | 2006-03-15 |
| EP1611106B1 (en) | 2006-09-20 |
| WO2004087671A1 (en) | 2004-10-14 |
| DK1611106T3 (da) | 2006-12-27 |
| CA2517451C (en) | 2009-04-21 |
| KR20050115323A (ko) | 2005-12-07 |
| PL1611106T3 (pl) | 2007-01-31 |
| AU2004226154A1 (en) | 2004-10-14 |
| EP1611106A1 (en) | 2006-01-04 |
| TWI284637B (en) | 2007-08-01 |
| CA2517451A1 (en) | 2004-10-14 |
| MXPA05010498A (es) | 2005-11-16 |
| AU2004226154B2 (en) | 2007-03-08 |
| ATE340161T1 (de) | 2006-10-15 |
| DE602004002473T2 (de) | 2007-06-14 |
| RU2298004C2 (ru) | 2007-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200833682A (en) | Pharmaceutical compounds | |
| AR057874A1 (es) | Aminopirimidinas utiles como inhibidores de quinasa | |
| CY1107168T1 (el) | Παραγωγα φαινυλοαλκανοϊκου οξεος και φαινυλοξυαλκανοϊκου οξεος ως ενεργοποιηται hppar | |
| AR051754A1 (es) | Metodos para preparar compuestos de indazol | |
| LU93078I2 (fr) | Combimetinib, éventuellement sous toute forme protégée par le brevet de base, y compris les sels et solvates pharmaceutiquement acceptables, en particulier hémifumarate de cobimetinib | |
| CO6531452A2 (es) | Piperidinas sustituidas que aumentan la actividad de p53 y sus usos | |
| EA200700901A1 (ru) | Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии | |
| ECSP056127A (es) | Inhibidores de 3-quinasa de fosfatidil-inositol | |
| CO6321248A2 (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
| AR050518A1 (es) | Proceso de amonolisis para la preparacion de intermedarios para inhibidores de dpp iv | |
| HRP20120006T1 (hr) | Derivat bicikloestera | |
| DK1506203T3 (da) | Syntese af epothiloner, mellemprodukter deraf, analoger deraf og anvendelser deraf | |
| CO5720995A2 (es) | Compuesto novedoso | |
| TW200626564A (en) | Carboxylic acid derivative containing thiazole ring and medical use thereof | |
| HN2003000243A (es) | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz | |
| MA28144A1 (fr) | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables | |
| DE602004026903D1 (de) | P-glycoprotein-inhibitor, verfahren zu dessen hersiesen enthält | |
| MX2022005732A (es) | Derivado de amida y metodo de preparacion para el mismo y uso del mismo en medicina. | |
| EA200500690A1 (ru) | Новые соединения пиридопиримидинона, способ их получения и фармацевтические композиции, которые их содержат | |
| AR050956A1 (es) | Derivados de bencimidazol; sintesis de los mismos; composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por ligandos del receptor cb1. | |
| AR040441A1 (es) | Compuesto de tiol, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento, procedimiento para prepararlo y compuesto intermediario de utilidad en dicho procedimiento | |
| DOP2006000248A (es) | Acido 1-(1-(2-etoxietil)-3-etil-7-(4-metilpiridin-2-ilamino)-1h- pirazolo[4,3-d]pirimidin-5-il)piperidina-4-carboxílico y las sales del mismo. | |
| AR043949A1 (es) | Preparacion de clorhidrato de quinapril | |
| SE0401655D0 (sv) | New compounds | |
| CY1108238T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |